← Leaderboards
Lenard M Lichtenberger
University Of Texas Hlth Sci Ctr Houston
$8,121,394
Attributed
$8,121,394
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,121,394 · 12
By mechanism
R42$4,321,787 · 2
RC1$992,972 · 1
P30$789,929 · 2
R21$765,880 · 2
R01$568,251 · 1
R41$393,226 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Pooja Shivshankar$585,000
- Rick A. Wetsel$8,477,213
- Eric A Boerwinkle$148,432,538
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsUlcerGastrointestinal Tract StructureLecithinAspirinGastrointestinalChronicRodentAdverse EffectsLaboratoriesMucous MembraneBaseRodent ModelCessation Of LifeAnimalsDoseTissuesGrantMalignant NeoplasmsIbuprofenBiological ModelsPreventRattusNon-Steroidal Anti-Inflammatory Agents
Grant awards (33)
Aspirin-PC for Chemoprevention of Colorectal Cancer$65,000
R42 · FY2019 · CA · contact PI
Aspirin-PC for Chemoprevention of Colorectal Cancer$966,160
R42 · FY2018 · CA · contact PI
Aspirin-PC for Chemoprevention of Colorectal Cancer$961,499
R42 · FY2017 · CA · contact PI
Surfactant lipids and associated proteins in radiation-induced mucositis$169,540
R21 · FY2017 · CA · contact PI
INTEGRATIVE BIOLOGY$155,160
P30 · FY2017 · DK · contact PI
Surfactant lipids and associated proteins in radiation-induced mucositis$216,743
R21 · FY2016 · CA · contact PI
INTEGRATIVE BIOLOGY$155,161
P30 · FY2016 · DK · contact PI
Effects of Antiplatelet Drugs on Colon Cancer in the Elderly$166,279
R21 · FY2015 · CA · contact PI
INTEGRATIVE BIOLOGY$155,161
P30 · FY2015 · DK · contact PI
Effects of Antiplatelet Drugs on Colon Cancer in the Elderly$213,318
R21 · FY2014 · CA · contact PI
INTEGRATIVE BIOLOGY$155,161
P30 · FY2014 · DK · contact PI
Aspirin-PC for Chemoprevention of Colorectal Cancer$146,908
R41 · FY2014 · CA · contact PI
INTEGRATIVE BIOLOGY$169,286
P30 · FY2013 · DK · contact PI
Aspirin-PC for Chemoprevention of Colorectal Cancer$147,318
R41 · FY2013 · CA · contact PI
PC-NSAIDs for Chemoprevention of Colorectal Cancer$71,440
R03 · FY2013 · CA · contact PI
PC-NSAIDs for Chemoprevention of Colorectal Cancer$76,000
R03 · FY2012 · CA · contact PI
NSAID-Phosphatidylcholine Association: Insight in GI Ulcer Pathogenesis/Therapy$499,896
RC1 · FY2010 · DK · contact PI
Gastrointestinal safety and therapeutics of oil-based Phosphatidylcholine-NSAIDS$37,500
R42 · FY2010 · DK · contact PI
NSAID-Phosphatidylcholine Association: Insight in GI Ulcer Pathogenesis/Therapy$493,076
RC1 · FY2009 · DK · contact PI
Gastrointestinal safety and therapeutics of oil-based Phosphatidylcholine-NSAIDS$464,675
R42 · FY2009 · DK · contact PI
Gastrointestinal safety and therapeutics of oil-based Phosphatidylcholine-NSAIDS$501,617
R42 · FY2008 · DK · contact PI
Gastrointestinal safety and therapeutics of oil-based Phosphatidylcholine-NSAIDS$566,719
R42 · FY2007 · DK · contact PI
GI safety and therapeutics of oil-based PC-NSAIDs$383,621
R42 · FY2005 · DK
GI safety and therapeutics of oil-based PC-NSAIDs$374,996
R42 · FY2004 · DK
Clinical Studies with Phospholipid-Associated NSAIDs$67,159
R03 · FY2004 · DK
PHOSPHOLIPIDS AND ULCER PROTECTION$116,174
R01 · FY2002 · DK
GI safety and therapeutics of oil-based PC-NSAIDs$99,000
R41 · FY2002 · DK
Core--Integrative Biology$0
P30 · FY2002 · DK
Core--Integrative Biology$0
P30 · FY2002 · DK
PHOSPHOLIPIDS AND ULCER PROTECTION$229,340
R01 · FY2001 · DK
Clinical Studies with Phospholipid-Associated NSAIDs$74,750
R03 · FY2001 · DK
Core--Integrative Biology$0
P30 · FY2001 · DK
PHOSPHOLIPIDS AND ULCER PROTECTION$222,737
R01 · FY2000 · DK